Fritsche HA - Search Results

1

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.

Sahin AA, Ro J, Ro JY, Blick MB, el-Naggar AK, Ordonez NG, Fritsche HA, Smith TL, Hortobagyi GN, Ayala AG. Sahin AA, et al. Among authors: fritsche ha. Cancer. 1991 Aug 1;68(3):549-57. doi: 10.1002/1097-0142(19910801)68:3<549::aid-cncr2820680318>3.0.co;2-j. Cancer. 1991. PMID: 1648433

2

c-erbB-2 amplification in node-negative human breast cancer.

Ro JS, el-Naggar A, Ro JY, Blick M, Frye D, Fraschini G, Fritsche H, Hortobagyi G. Ro JS, et al. Cancer Res. 1989 Dec 15;49(24 Pt 1):6941-4. Cancer Res. 1989. PMID: 2573424

3

Sequential cyclic combined hormonal therapy for metastatic breast cancer.

Hortobagyi GN, Hug V, Buzdar AU, Kau SW, Holmes FA, Fritsche HA. Hortobagyi GN, et al. Among authors: fritsche ha. Cancer. 1989 Sep 1;64(5):1002-6. doi: 10.1002/1097-0142(19890901)64:5<1002::aid-cncr2820640505>3.0.co;2-b. Cancer. 1989. PMID: 2527085

4

The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy.

Theriault RL, Hortobagyi GN, Fritsche HA, Frye D, Martinez R, Buzdar AU. Theriault RL, et al. Among authors: fritsche ha. Cancer. 1989 Mar 1;63(5):828-35. doi: 10.1002/1097-0142(19890301)63:5<828::aid-cncr2820630506>3.0.co;2-3. Cancer. 1989. PMID: 2914290

5

Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content.

El-Naggar AK, Kemp BL, Sneige N, Hurr KG, Steck K, Tu ZN, Fritsche HA, Singletary SE, Balch CM. El-Naggar AK, et al. Among authors: fritsche ha. Clin Cancer Res. 1996 Feb;2(2):419-26. Clin Cancer Res. 1996. PMID: 9816186

6

Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas.

Katz RL, Patel S, Sneige N, Fritsche HA Jr, Hortobagyi GN, Ames FC, Brooks T, Ordonez NG. Katz RL, et al. Among authors: fritsche ha jr. Breast Cancer Res Treat. 1990 May;15(3):191-203. doi: 10.1007/BF01806356. Breast Cancer Res Treat. 1990. PMID: 1695528

7

Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.

Mazouni C, Hall A, Broglio K, Fritsche H, Andre F, Esteva FJ, Hortobagyi GN, Buzdar AU, Pusztai L, Cristofanilli M. Mazouni C, et al. Cancer. 2007 Feb 1;109(3):496-501. doi: 10.1002/cncr.22418. Cancer. 2007. PMID: 17149760 Free article. Clinical Trial.

8

Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?

Dawood S, Broglio K, Valero V, Reuben J, Handy B, Islam R, Jackson S, Hortobagyi GN, Fritsche H, Cristofanilli M. Dawood S, et al. Cancer. 2008 Nov 1;113(9):2422-30. doi: 10.1002/cncr.23852. Cancer. 2008. PMID: 18785255 Free article. Clinical Trial.

9

Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia.

Singletary SE, Atkinson EN, Hoque A, Sneige N, Sahin AA, Fritsche HA Jr, Lotan R, Lu T, Hittelman WN, Bevers TB, Stelling CB, Lippman SM. Singletary SE, et al. Among authors: fritsche ha jr. Clin Cancer Res. 2002 Sep;8(9):2835-42. Clin Cancer Res. 2002. PMID: 12231524 Clinical Trial.

10

Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer.

Ro J, Sahin A, Ro JY, Fritsche H, Hortobagyi G, Blick M. Ro J, et al. Hum Pathol. 1990 Aug;21(8):787-91. doi: 10.1016/0046-8177(90)90046-8. Hum Pathol. 1990. PMID: 1974874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters